CDC: Supplement: collected recommendations of the Public Health Service Advisory Committee on Immunization Practices. MMWR. 1972, 2: 1-
Google Scholar
Breman JG, Arita I: The confirmation and maintenance of smallpox eradication. N Engl J Med. 1980, 303 (22): 1263-73.
Article
CAS
PubMed
Google Scholar
CDC: Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR. 2003, 52 (RR-7):
Mayr A, Stickl H, Müller HK, Danner K, Singer H: The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism. Zbl Bakt Hyg I Abt Orig B. 1978, 167: 375-390.
CAS
Google Scholar
Stittelaar KJ, Kuiken T, de Swart RL, van Amerongen G, Vos HW, Niesters HG, van Schalkwijk P, van der Kwast T, Wyatt LS, Moss B, Osterhaus AD: Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine. 2001, 19 (27): 3700-3709. 10.1016/S0264-410X(01)00075-5.
Article
CAS
PubMed
Google Scholar
EN 14476: Chemical disinfectants and antiseptics. Virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine. Test method and requirements (phase 2, step 1). 2007
Google Scholar
Blümel J, Glebe D, Neumann-Haefelin D, Rabenau HF, Rapp I, von Rheinbaben F, Ruf B, Sauerbrei A, Schwebke I, Steinmann J, Willkommen H, Wolff MH, Wutzler P: Guideline of "Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V." (DVV; German Association for the Control of Virus Diseases) and Robert Koch-Institute (RKI; German Federal Health Authority) for testing the virucidal efficacy of chemical disinfectants in the human medical area. Hyg Med. 2009, 34 (7/8): 293-299.
Google Scholar
Anonymous: Prüfung und Deklaration der Wirksamkeit von Desinfektionsmitteln gegen Viren. Stellungnahme des Arbeitskreises Viruzidie beim Robert Koch-Institut (RKI) sowie des Fachausschusses Virusdesinfektion der Deutschen Gesellschaft zur Bekämpfung der Viruskrankheiten (DVV) und der Desinfektionsmittelkommission der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM). Bundesgesundhbl. 2004, 47 (1): 62-66. 10.1007/s00103-003-0754-7.
Article
Google Scholar
Anonymous: Richtlinien zur Prüfung chemischer Desinfektionsmittel für die Veterinärmedizin. Deutsche Veterinärmedizinische Gesellschaft e. V., Gießen. 2000
Google Scholar
Auckland C, Cowlishaw A, Morgan D, Miller E: Reactions to small pox vaccine in naïve and previously-vaccinated individuals. Vaccine. 2005, 23: 4185-4187. 10.1016/j.vaccine.2004.10.052.
Article
CAS
PubMed
Google Scholar
Eckart RE, Shry EA, Jones SO, Atwood JE, Grabenstein JD: Comparison of clinical presentation of acute myocarditis following smallpox vaccination to acute coronary syndromes in patients <40 years of age. Am J Cardiol. 2005, 95 (10): 1252-1255. 10.1016/j.amjcard.2005.01.061.
Article
PubMed
Google Scholar
Sejvar JJ, Labutta RK, Chapman LE, Grabenstein JD, Iskander J, Lane JM: Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA. 2005, 294 (21): 2744-2750. 10.1001/jama.294.21.2744.
Article
CAS
PubMed
Google Scholar
CDC: Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR. 2006, 55 (RR-1):
CDC: Laboratory-acquired vaccinia exposures and infections---United States, 2005--2007. MMWR. 2008, 57: 401-404.
Google Scholar
Lewis FM, Chernak E, Goldman E, Li Y, Karem K, Damon IK, Henkel R, Newbern EC, Ross P, Johnson CC: Ocular vaccinia infection in laboratory worker, Philadelphia, 2004. Emerg Infect Dis. 2006, 12: 134-137.
Article
PubMed
PubMed Central
Google Scholar
Mempel M, Isa G, Klugbauer N, Meyer H, Wildi G, Ring J, Hofmann F, Hofmann H: Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct. J Invest Dermatol. 2003, 120 (3): 356-358. 10.1046/j.1523-1747.2003.12074.x.
Article
CAS
PubMed
Google Scholar
Openshaw PJM, Alwan WH, Cherrie AH, Record FM: Accidental infection of laboratory worker with recombinant vaccinia virus. Lancet. 1991, 338: 459-10.1016/0140-6736(91)91093-A.
Article
CAS
PubMed
Google Scholar
Rupprecht CE, Blass L, Smith K, Orciari LA, Niezgoda M, Whitfield SG, Gibbons RV, Guerra M, Hanlon CA: Human infection due to recombinant vaccinia-rabies glycoprotein virus. N Engl J Med. 2001, 345: 582-586. 10.1056/NEJMoa010560.
Article
CAS
PubMed
Google Scholar
Wlodaver CG, Palumbo GJ, Waner JL: Laboratory-acquired vaccinia infection. J Clin Virol. 2004, 29: 167-170. 10.1016/S1386-6532(03)00118-5.
Article
PubMed
Google Scholar
CDC: Laboratory-Acquired Vaccinia Virus Infection - Virginia, 2008. MMWR. 2009, 58 (29): 797-800.
Google Scholar
Hartnack S, Essbauer S, Truyen U: Substitution of vaccinia virus Elstree by modified vaccinia virus Ankara to test the virucidal efficacy of chemical disinfectants. Zoonoses Public Health. 2008, 55 (2): 99-105.
Article
CAS
PubMed
Google Scholar
Spearman C: The method of "right and wrong cases" ("constant stimuli") without Gauss's formulae. British Journal of Psychology. 1908, 2: 227-242.
Google Scholar
Kaerber G: Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Path Pharmako. 1931, 162: 480-483. 10.1007/BF01863914.
Article
Google Scholar
Slifka MK: The future of smallpox vaccination: is MVA the key?. Med Immunol. 2005, 4 (1): 2-10.1186/1476-9433-4-2.
Article
PubMed
PubMed Central
Google Scholar
Kemper A, Davis M, Freed G: Expected adverse events in a mass smallpox vaccination campaign. Effect Clin Pract. 2002, 5: 84-90.
Google Scholar
Just I, Finke H: A contribution to the stability of the MVA-vaccine. ZBL Bakt Hyg I Abt Orig. 1979, A245: 276-282.
Google Scholar
Newman FK, Frey SE, Blevins TP, Yan L, Belshe RB: Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax. J Infect Dis. 2003, 187 (8): 1318-1322. 10.1086/374564.
Article
Google Scholar
Kline RL, Regnery RL, Armstrong GL, Damon IK: Stability of diluted smallpox vaccine under simulated clinical conditions. Vaccine. 2005, 23 (41): 4944-4946. 10.1016/j.vaccine.2005.05.016.
Article
CAS
PubMed
Google Scholar
Lee KN, Hutson CL, Kline R, Curns AT, Dougherty C, Allen C, Damon I, Regnery R: Smallpox vaccine stability after maintenance at temperatures not recommended for shipping. Vaccine. 2006, 24 (7): 884-886. 10.1016/j.vaccine.2005.08.079.
Article
CAS
PubMed
Google Scholar